Image
Prithvi Mruthyunjaya
Professor - University Medical Line, Ophthalmology
Professor - University Medical Line (By courtesy), Radiation Oncology - Radiation Therapy
Member, Bio-X
Member, Stanford Cancer Institute
Member, Wu Tsai Neurosciences Institute
Fellowship: Duke University Medical Center Ophthalmology Fellowships (2004) NC
Internship: University of Rochester Internal Medicine Residency (1997) NY
Medical Education: Albany Medical College (1996) NY
MHS, Duke University School of Medicine, Health Science in Clinical Research (2016)
Fellowship, Moorfields Eye Hospital, London UK, Ocular Oncology (2005)
Fellowship, Duke University Eye Center, Vitreoretinal Surgery (2004)
Chief Resident, Duke University Eye Center, Ophthalmology (2002)
Residency, Duke University Eye Center, Ophthalmology (2000)
MD, Albany Medical College, Medicine (1996)
BS, Renselaer Polytechnic Institue, Bioloy (1994)
Affiliation:
**DR MRUTHYUNJAYA IS AVAILABLE TO CARE FOR ADULT AND PEDIATRIC PATIENTS WITH EYE CANCERS AND ADULTS with COMPLEX RETINAL DISEASES**
Prithvi Mruthyunjaya MD, MHS is Professor of Ophthalmology and Associate Professor of Radiation Oncology (by courtesy) at Stanford Univeristy, Director of Ocular Oncology at the Byers Eye Institute, and member of the Vitreoretinal Surgery Service. He is a board certified ophthalmologist who has completed two prestigious fellowships: the first in Vitreoretinal Surgery at Duke University and the second in Ocular Oncology at Moorfields Eye Hospital in London, England.
He cares for patients with conditions related to cancer of the eye in both adults and children--either benign, pre-cancerous, or malignant. These conditions include ocular melanoma, hemangioma, cancers from other parts of the body which spread to the eye, Coats' disease, retinoblastoma, iris tumors (melanoma, cysts, metastatic lesions) and tumors of the conjunctiva including melanoma, and squamous cells carcinoma. He also manages the eye-related side effects of chemotherapy treatments. He is an expert in using the most advanced diagnostic tests to make a personalized treatment plan for every patient. With his expertise in retinal surgery, he treats patients with a variety of advanced techniques including small instrument tumor biopsy, vitrectomy, and radiation therapy. His approach to any patient is to provide customized care for every patient and works closely with other experts at the Stanford Cancer Institute.
As a retinal surgeon, he manages complicated retinal diseases including retinal detachment, macular holes, epiretinal membranes, and diabetic eye disease.
Dr. Mruthyunjaya is actively involved in research in ocular cancer imaging, genetics, and new modalities of tumor biopsy. He actively participates in early phase clinical trial development in ocular oncology and has brought cutting-edge treatment options to his patients at Stanford. He has published extensively in the field of ocular oncology, ophthalmic imaging, and complex retinal surgery. In addition he holds leadership positions in the American Academy of Ophthalmology (AAO), the Retina Society, and the Intenational Society of Ocular Oncology.
His passion lies in developing collaborative research networks and training the next generation of vitreoretinal surgeons. He serves as the Vitreoretinal Surgery Fellowship Director at Stanford. His academic contributions were recognized by the Heed, AOS-Knapp and Ronald G Michels foundations and the American Society of Retina Specialists with their Senior Honor Award. He has received the Senior Achievement and Secretariat Award by the American Academy of Ophthalmology. He was recently listed as one of the worlds 150 most innovative retinal specialists and is a 2022 inductee in the Global Retinal Hall of Fame.
BIOGRAPHY:
He grew up in Upstate New York and was selected for the highly prestigious accelerated 6-year medical program completing his undergraduate studies at Rensselaer in 2 years then moving on to complete his medical studies at Albany Medical College where he was elected to the Alpha Omega Alpha honor society. . At the Duke Eye Center in Durham, NC, he finished his Ophthalmology residency, Chief Residency, and clinical-research fellowships in Vitreoretinal surgery followed by an Ocular Oncology fellowship at the Moorfields Eye Hospital in London, UK. He returned to Duke University where he served on faculty for 15 years building a comprehensive eye cancer service.
He joined the faculty of the Byers Eye Institute where he has established a state-of-the-art ocular oncology service at Stanford University in Palo Alto, CA. His passion includes teaching the next generation of students, residents and fellows and currently serves as the retinal surgery fellowship director at Stanford. He has enjoyed moving to the Bay area with his family.
Prithvi Mruthyunjaya MD, MHS is Professor of Ophthalmology and Associate Professor of Radiation Oncology (by courtesy) at Stanford Univeristy, Director of Ocular Oncology at the Byers Eye Institute, and member of the Vitreoretinal Surgery Service. He is a board certified ophthalmologist who has completed two prestigious fellowships: the first in Vitreoretinal Surgery at Duke University and the second in Ocular Oncology at Moorfields Eye Hospital in London, England.
He cares for patients with conditions related to cancer of the eye in both adults and children--either benign, pre-cancerous, or malignant. These conditions include ocular melanoma, hemangioma, cancers from other parts of the body which spread to the eye, Coats' disease, retinoblastoma, iris tumors (melanoma, cysts, metastatic lesions) and tumors of the conjunctiva including melanoma, and squamous cells carcinoma. He also manages the eye-related side effects of chemotherapy treatments. He is an expert in using the most advanced diagnostic tests to make a personalized treatment plan for every patient. With his expertise in retinal surgery, he treats patients with a variety of advanced techniques including small instrument tumor biopsy, vitrectomy, and radiation therapy. His approach to any patient is to provide customized care for every patient and works closely with other experts at the Stanford Cancer Institute.
As a retinal surgeon, he manages complicated retinal diseases including retinal detachment, macular holes, epiretinal membranes, and diabetic eye disease.
Dr. Mruthyunjaya is actively involved in research in ocular cancer imaging, genetics, and new modalities of tumor biopsy. He actively participates in early phase clinical trial development in ocular oncology and has brought cutting-edge treatment options to his patients at Stanford. He has published extensively in the field of ocular oncology, ophthalmic imaging, and complex retinal surgery. In addition he holds leadership positions in the American Academy of Ophthalmology (AAO), the Retina Society, and the Intenational Society of Ocular Oncology.
His passion lies in developing collaborative research networks and training the next generation of vitreoretinal surgeons. He serves as the Vitreoretinal Surgery Fellowship Director at Stanford. His academic contributions were recognized by the Heed, AOS-Knapp and Ronald G Michels foundations and the American Society of Retina Specialists with their Senior Honor Award. He has received the Senior Achievement and Secretariat Award by the American Academy of Ophthalmology. He was recently listed as one of the worlds 150 most innovative retinal specialists and is a 2022 inductee in the Global Retinal Hall of Fame.
BIOGRAPHY:
He grew up in Upstate New York and was selected for the highly prestigious accelerated 6-year medical program completing his undergraduate studies at Rensselaer in 2 years then moving on to complete his medical studies at Albany Medical College where he was elected to the Alpha Omega Alpha honor society. . At the Duke Eye Center in Durham, NC, he finished his Ophthalmology residency, Chief Residency, and clinical-research fellowships in Vitreoretinal surgery followed by an Ocular Oncology fellowship at the Moorfields Eye Hospital in London, UK. He returned to Duke University where he served on faculty for 15 years building a comprehensive eye cancer service.
He joined the faculty of the Byers Eye Institute where he has established a state-of-the-art ocular oncology service at Stanford University in Palo Alto, CA. His passion includes teaching the next generation of students, residents and fellows and currently serves as the retinal surgery fellowship director at Stanford. He has enjoyed moving to the Bay area with his family.